Acute myeloid leukemia (AML) is a neoplasm of immature myeloid cells and is associated with a wide variety of clinical presentations, morphological features, immunophenotypes, and genetic findings. This lecture will address diagnosis of AML with a focus on revised World Health Organization (WHO) classification. In addition, range of ancillary techniques including next generation sequencing and minimal residual disease significance in AML is discussed.